Article Text
Abstract
Introduction We reviewed the management of Duodenal adenomas at James Paget University Hospital, Great Yarmouth between 2001 and 2013.
Methods 20 patients were included in this study. A standardised proforma was completed for each case and the information was then collated.
Results A CT scan was performed in 13/20 patients. 3/20 had CT and Endoscopic Ultrasound. 4/20 had no imaging. 14/20 patients had Endoscopic Mucosal Resection (EMR). 5/20 had surgery. 1/20 case was monitored with annual surveillance OGDs. 11/14 patients had EMR within 6 months of diagnosis. Complete resection was achieved in 11/14. Argon Plasma Coagulation (APC) was used in 3/14.
The American Society of Gastroenterology guidelines1 recommend routine insertion of prophylactic pancreatic stents for patients undergoing EMR of Ampullary adenomas. 6 of our patients had EMR for Ampullary adenoma and only 1 had a Pancreatic stent inserted. However none of these procedures were complicated by Pancreatitis. 4/14 patients had serious complications following EMR. 3 of these had bleeding from the EMR site while one had a large mucosal defect needing Endoclip application. The 30 day mortality was 0. The frequency of long term follow up was in compliance with the Spigelman scoring system.5 4/14 patients had recurrent Duodenal adenomas after EMR.
Various studies have previously demonstrated a high incidence of co-existing Colorectal neoplasms in patients with sporadic Duodenal adenomas.2–4 The same was observed in our patients. Of the 17/20 patients who had Duodenal adenomas and intact colons, 11 had a colonoscopy. 3 were found to have Colon cancer, 4 had Colonic adenomas and 1 had hyperplastic polyps.
Conclusion We recommend imaging for all polyps >1 cm. All patients should have EMR within 6 months of diagnosis. Only 1/6 patients who had EMR of ampullary lesions had a Pancreatic stent inserted. None developed Pancreatitis. 4/14 had serious complications following EMR. Long term follow up was in compliance with Spigelman scoring system. 4/14 had recurrent Duodenal adenomas after EMR. 3 patients were found to have Colon cancer. So it is essential that all patients with Duodenal adenomas have a colonoscopy.
References
-
The role of endoscopy in ampullary and duodenal adenomas. Gastrointestinal Endoscopy 2006; 64(6)
-
Murray et al., Sporadic duodenal adenoma is associated with colorectal neoplasia. Gut 2004
-
Ramsoekh et al., Sporadic duodenal adenoma and the association with colorectal neoplasia: a case-control study. The American Journal of Gastroenterology 2008
-
van Heumen et al., Management of sporadic duodenal adenomas and the association with colorectal neoplasms: a retrospective cohort study.J Clin Gastroenterol 2012 May
-
Spigelman et al., Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989
Disclosure of Interest None Declared.